Biography
Dr. Ashish Manne is an Associate Professor of Medical Oncology in the Division of Medical Oncology at The Ohio State University's Comprehensive Cancer Center (The James), where he specializes in gastrointestinal, pancreatic, and hepatobiliary malignancies. He serves as Co-Director of the Pancreatic Cancer Multidisciplinary Care Clinic and is the Founder and Faculty Lead of Nucleus, an AI-enabled oncology intelligence platform, and leads the OSUCCC Artificial Intelligence in Medical Oncology Task Force. Dr. Manne's research bridges clinical oncology, translational science, and artificial intelligence, with a focus on biomarkers, the tumor immune microenvironment, digital pathology, and computational oncology. He is Principal Investigator on multiple translational and industry-sponsored research programs, including a national multicenter investigator-initiated trial in resectable pancreatic cancer through the Big Ten Cancer Research Consortium. His work on MUC5AC biology and cfDNA methylation signatures has advanced biomarker-driven approaches to precision medicine in pancreatic and hepatocellular cancers. He has authored more than 50 peer-reviewed publications and 80 national and international abstracts, and has presented at ASCO, AACR, ASCO GI, USCAP, and ICML. He serves on the editorial boards of Targeted Oncology and Frontiers in Immunology, and has mentored 22 trainees spanning faculty, fellows, residents, and students.
Financial Disclosure
Awaiting faculty disclosure.